Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Judson

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|January 1, 1996
Computational evolution of a model polymer that folds to a specified target conformationR Judson
The Medical Journal of Australia|April 30, 1983
Pressure soresR Judson
Australian Family Physician|November 5, 1997
Minor burns. Modern management techniquesR Judson
Anti-Cancer Drugs|August 1, 1997
'Tomudex' (raltitrexed) development: preclinical, phase I and II studiesI R Judson
Seminars in Oncology|December 1, 1992
The anthrapyrazoles: a new class of compounds with clinical activity in breast cancerI R Judson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Imatinib for patients with liver or kidney dysfunction: no need to modify the doseIan R Judson
Anti-Cancer Drugs|June 1, 1991
Anthrapyrazoles: true successors to the anthracyclines?I R Judson
British Journal of Cancer|August 1, 1989
New endocrine agents, guidelines for future developmentI R Judson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Prognosis, imatinib dose, and benefit of sunitinib in GIST: knowing the genotypeIan R Judson
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II studies: wrong doses, wrong patients?I R Judson
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|January 1, 1996
Computational evolution of a model polymer that folds to a specified target conformationR Judson
The Medical Journal of Australia|April 30, 1983
Pressure soresR Judson
Australian Family Physician|November 5, 1997
Minor burns. Modern management techniquesR Judson
Anti-Cancer Drugs|August 1, 1997
'Tomudex' (raltitrexed) development: preclinical, phase I and II studiesI R Judson
Seminars in Oncology|December 1, 1992
The anthrapyrazoles: a new class of compounds with clinical activity in breast cancerI R Judson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Imatinib for patients with liver or kidney dysfunction: no need to modify the doseIan R Judson
Anti-Cancer Drugs|June 1, 1991
Anthrapyrazoles: true successors to the anthracyclines?I R Judson
British Journal of Cancer|August 1, 1989
New endocrine agents, guidelines for future developmentI R Judson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Prognosis, imatinib dose, and benefit of sunitinib in GIST: knowing the genotypeIan R Judson
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II studies: wrong doses, wrong patients?I R Judson
Pageof 14